Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 12 min ago
Peer-reviewedCC BY-NC 4.0Catheterization and Cardiovascular Interventions

Maximum Allowable Contrast Dose and Risk of Acute Kidney Injury After Coronary Procedures

  • Harshita Gaba1
  • Elise Mesenbring2
  • Christine Chow1
  • Jennifer A. Rymer3
  • Celina M. Yong4,5
  • Stephen W. Waldo2,6,7
  • Jacob A. Doll1,8
8 affiliations
  1. 1University of Washington Seattle Washington USA
  2. 2CART Program Office of Quality and Patient Safety, Veterans Health Administration Washington DC USA
  3. 3Duke University Medical Center Durham North Carolina USA
  4. 4Veterans Affairs Palo Alto Healthcare System Palo Alto California USA
  5. 5Stanford University School of Medicine Stanford California USA
  6. 6Rocky Mountain Regional VA Medical Center Aurora Colorado USA
  7. 7University of Colorado Aurora Colorado USA
  8. 8VA Puget Sound Health Care System Seattle Washington USA
Read full textPDFDOICite

Abstract

Background: Recent studies have questioned whether iodinated contrast is causally related to acute kidney injury (AKI).

AIM: We pursed a contemporary analysis to determine the impact of contrast dose on AKI following coronary procedures in an era of lower contrast doses and less nephrotoxic agents.

Methods: This national cohort study examined patients who had percutaneous coronary intervention (PCI) or diagnostic angiography from October 2010 to May 2023. We used logistic regression to test associations between (1) baseline (pre‐procedural) AKI risk and contrast dose, and (2) contrast dose and post‐procedure AKI. Contrast exposure was quantified as a proportion of the maximal allowable contrast dose (MACD; 2.5 mL × body weight (kg)/serum creatinine).

Results: Median contrast volume decreased during our study period for PCI (200 to 150 mL, p < 0.01) and angiography (95 to 60 mL, p < 0.01). In the combined cohort of 175,963 procedures, the mean patient age was 68.5 years; 97.5% were male. Decile plots revealed that patients at higher baseline risk of AKI received lower contrast volumes. When the contrast dose exceeded MACD, there was a stepwise association between contrast dose and adjusted odds of AKI. The highest odds of AKI were observed for patients with eGFR < 30 who received > 200% of the MACD (OR, 2.89; 95% CI, 2.21 to 3.79).

Conclusions: In this large national cohort of patients undergoing coronary procedures, there was a reduction in contrast dose over time and evidence that physicians are reducing contrast volume for high‐risk patients. The MACD remains a reasonable target to reduce AKI.

Related

  1. Ultra-low contrast intravascular ultrasound-guided percutaneous coronary intervention of the left main and left anterior descending artery in advanced chronic kidney disease
    Grzegorz Jodlowski, Dawid Ilnicki, Lukasz Osuch +3
    Postepy w kardiologii interwencyjnej = Advances in interventional cardiologyPeer-reviewedCC BY-NC-SAFull textSurgery & anaesthesiaEurope PMCPMC
  2. Association of FIB-4 and APRI with Contrast-Associated Acute Kidney Injury in Patients with Non-ST-Segment Elevation Myocardial Infarction Undergoing Coronary Angiography
    Duygu Genç Albayrak, Duygu İnan, Osman Uzman +7
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0General medicineCrossref
  3. Comparative perioperative and follow-up outcomes of three laparoscopic reconstructive procedures for pediatric duplex kidney : A retrospective cohort study
    Hongchao Chai, Jingru Wang, Jingtao Li +1
    MedicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  4. Combined non-contrast enhancement 3D bright-blood and 2D black-blood coronary magnetic resonance angiography for the assessment of coronary artery stenosis
    Qiu-Ju Hu, Di Tian, Dong-Sheng Jin +7
    Quantitative imaging in medicine and surgeryPeer-reviewedCC BY-NC-NDFull textMedical imaging & radiologyEurope PMC
  5. Hypertrophic obstructive cardiomyopathy complicated by severe midventricular obstruction treated with percutaneous transluminal septal myocardial ablation using simultaneous contrast imaging with left ventriculography and coronary angiography: a case report
    European heart journal. Case reportsPeer-reviewedCC BYFull textCardiovascular medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{gaba2026maximum,
  title = {{Maximum Allowable Contrast Dose and Risk of Acute Kidney Injury After Coronary Procedures}},
  author = {Harshita Gaba and Elise Mesenbring and Christine Chow and Jennifer A. Rymer and Celina M. Yong and Stephen W. Waldo and Jacob A. Doll},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2026},
  month = sep,
  doi = {10.1002/ccd.70854},
  url = {https://doi.org/10.1002/ccd.70854},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Maximum Allowable Contrast Dose and Risk of Acute Kidney Injury After Coronary Procedures
AU  - Harshita Gaba
AU  - Elise Mesenbring
AU  - Christine Chow
AU  - Jennifer A. Rymer
AU  - Celina M. Yong
AU  - Stephen W. Waldo
AU  - Jacob A. Doll
PY  - 2026
DA  - 2026/09/08
JO  - Catheterization and Cardiovascular Interventions
DO  - 10.1002/ccd.70854
UR  - https://doi.org/10.1002/ccd.70854
AB  - Background: Recent studies have questioned whether iodinated contrast is causally related to acute kidney injury (AKI).  AIM: We pursed a contemporary analysis to determine the impact of contrast dose on AKI following coronary procedures in an era of lower contrast doses and less nephrotoxic agents.  Methods: This national cohort study examined patients who had percutaneous coronary intervention (PCI) or diagnostic angiography from October 2010 to May 2023. We used logistic regression to test associations between (1) baseline (pre‐procedural) AKI risk and contrast dose, and (2) contrast dose and post‐procedure AKI. Contrast exposure was quantified as a proportion of the maximal allowable contrast dose (MACD; 2.5 mL × body weight (kg)/serum creatinine).  Results: Median contrast volume decreased during our study period for PCI (200 to 150 mL, p < 0.01) and angiography (95 to 60 mL, p < 0.01). In the combined cohort of 175,963 procedures, the mean patient age was 68.5 years; 97.5% were male. Decile plots revealed that patients at higher baseline risk of AKI received lower contrast volumes. When the contrast dose exceeded MACD, there was a stepwise association between contrast dose and adjusted odds of AKI. The highest odds of AKI were observed for patients with eGFR < 30 who received > 200% of the MACD (OR, 2.89; 95% CI, 2.21 to 3.79).  Conclusions: In this large national cohort of patients undergoing coronary procedures, there was a reduction in contrast dose over time and evidence that physicians are reducing contrast volume for high‐risk patients. The MACD remains a reasonable target to reduce AKI.
SN  - 1522-1946
SN  - 1522-726X
ER  -